Bringspring Science & Technology Co., Ltd. Class A

Bringspring Science & Technology Co., Ltd. Class A

SSZSE:300290
4.70
CNY
+0.06
(+1.29%)
-0.29EPS
4.27BMarket Cap
Bringspring Science & Technology Co., Ltd. Class A
SZSE:300290
(Shenzhen Stock Exchange)

Recent

price

4.70

P/E

ratio

- -

div

yld

0.44%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.56
0.8
0.86
0.92
1.01
1.22
1.04
0.87
1.26
1.33
1.38
1.32
1.1
1.25
1.21
1.18
1.09
Revenue per Share
0.12
0.15
0.13
0.13
0.14
0.11
0.07
0.04
0.04
0.08
0.14
-0.65
-0.35
0.04
- -
-0.07
-0.3
Basic EPS, GAAP
0.03
0.14
- -
-0.34
-0.15
0.07
- -
-0.05
0.15
0.09
0.14
-0.1
-0.04
0.05
-0.07
-0.12
- -
Free Cash Flow per Basic Share
- -
- -
0.04
0.03
0.04
0.04
0.02
0.02
0.02
0.03
0.03
0.04
0.01
- -
- -
- -
0.02
Dividend per Share
0.33
0.47
0.84
0.95
1.06
1.77
1.83
1.47
1.74
1.95
2.29
1.62
1.27
1.29
1.28
1.19
0.9
Book Value per Share
0.33
0.47
0.84
0.91
0.99
1.44
1.49
1.12
0.99
1.24
1.37
1.01
0.85
0.86
0.85
0.74
0.45
Tangible Book Value per Share
288
306
391
408
408
445
482
482
499
543
573
619
638
640
635
639
640
Basic Weighted Avg Shares
162
244
335
376
412
542
503
419
627
724
788
817
705
798
767
755
695
Sales/Revenue/Turnover
23.13
19.64
16.51
16.4
16.55
13.72
11.37
5.98
9.6
11.06
12.17
-6.45
-4.56
11.09
3.1
2.91
-1.43
Operating Margin (%)
1
3
3
3
7
10
11
15
22
26
30
36
22
29
32
30
- -
Depreciation Expense
35
45
50
53
57
51
32
19
20
43
80
-405
-225
27
-3
-45
-193
Net Income, GAAP
12.33
16.19
15.94
11.76
7.78
9.12
6.84
12.86
11.53
3.74
0.47
- -
- -
21.41
24.82
- -
- -
Effective Tax Rate (%)
21.8
18.4
14.9
14.17
13.82
9.34
6.45
4.5
3.26
5.96
10.2
-49.53
-31.94
3.33
-0.38
-5.97
-27.72
Profit Margin (%)
75
109
286
306
323
613
582
426
338
484
611
541
436
487
467
413
352
Working Capital
8
- -
- -
- -
- -
- -
- -
68
68
52
26
17
17
11
19
12
11
LT Debt
101
146
345
395
443
875
904
710
885
1,084
1,411
1,084
861
887
897
831
639
Total Equity
42.22
26.28
16.66
11.45
10.11
7.17
3.98
1.94
2.51
4.25
7.35
- -
- -
5.03
0.86
- -
- -
Return on Invested Capital (%)
47.28
32.63
19.71
13.46
11.8
6.6
2.77
2.99
2.86
4.52
5.26
- -
- -
1.92
-1.18
- -
- -
Return on Capital (%)
53.57
36.7
20.43
14.58
13.9
7.86
3.73
2.36
2.56
4.4
6.58
-33.69
-24.38
3.24
-0.35
-5.69
-28.41
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
143
180
152
LT Borrowings
- -
- -
- -
LT Finance Leases
10
14
11
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
640
640
640
Market Capitalization
9,039
4,254
4,273

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,054
1,088
1,043
Cash, Cash Equivalents & STI
135
162
128
Accounts Receivable, Net
433
429
436
Inventories
374
394
387
Total Current Liabilities
646
724
691
Payables & Accruals
- -
- -
- -
ST Debt
143
180
152
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.22%
-9.39%
-7.39%
Free Cash Flow
210.99%
-127.18%
66.71%
Net Income, GAAP
70.14%
114.65%
1,444.08%
Sales/Revenue/Turnover
4.78%
-0.47%
-1.67%
Total Cash Common Dividend
-1.69%
-6.88%
134.84%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
121
193
161
292
767
2025
122
170
- -
301
755
2026
108
134
151
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
0.02
- -
0.01
- -
2025
-0.04
- -
- -
-0.02
-0.07
2026
-0.03
-0.21
-0.04
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
0.02
- -
- -
Business
Bringspring Science & Technology Co., Ltd. is a China-based technology enterprise principally engaged in the provision of healthcare information technology (HIT) software, medical big data analytics, intelligent clinical solutions, and enterprise IT infrastructure management services. Founded in 2005 and headquartered in Shenyang, Liaoning Province, China, the company delivers mission-critical software architectures, digital health platforms, and systems integration services to tertiary hospitals, healthcare administrative bureaus, government institutions, and large-scale enterprises across the People's Republic of China. The company operates primarily through its healthcare informatics, smart city, and IT services business segments. Its core product and service portfolio encompasses: clinical information software solutions, including anesthesia clinical information management systems; intensive care unit (ICU) clinical information management systems; digital integrated operating room systems; mobile inpatient nursing systems; emergency medical and trauma triage management platforms; electronic medical record (EMR) systems; clinical data repositories (CDR); and hospital information integration engines; healthcare big data and artificial intelligence solutions, comprising clinical decision support systems (CDSS); hospital-wide operational data centers (ODR); regional medical and healthcare data exchange platforms; disease surveillance and epidemiological analysis systems; and smart public health management applications; intelligent IT infrastructure and cloud management services, comprising data center planning, construction, and operation and maintenance (O&M); enterprise cloud management platforms; network security auditing and compliance integration; storage virtualization; and business continuity and disaster recovery solutions; and smart governance solutions, including municipal administrative information systems; smart education management platforms; and public utility automation infrastructure. In recent developments, Bringspring Science & Technology Co., Ltd. has executed significant strategic, organizational, and technological transformations to advance its position in high-value digital healthcare. Following a strategic ownership restructuring that introduced state-owned investment backing from Henan Information Industry Investment Group as a core controlling stakeholder, the company has aligned its long-term expansion with national medical digitization and localization programs. The company has accelerated the integration of artificial intelligence and large language models (LLMs) into its proprietary clinical software suite, enhancing automated clinical decision support, medical documentation processing, and hospital operational efficiency. Furthermore, Bringspring has expanded strategic ecosystem collaborations with domestic computing architecture providers, achieving compatibility and performance certifications with platforms such as Huawei's Kunpeng and Ascend technologies to support secure, localized healthcare deployments. Operationally, the company continues to optimize its revenue mix by prioritizing proprietary high-margin medical software and software-as-a-service (SaaS) subscriptions while phasing down lower-margin third-party hardware integration activities.